1. Home
  2. INKT vs LSTA Comparison

INKT vs LSTA Comparison

Compare INKT & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • LSTA
  • Stock Information
  • Founded
  • INKT 2017
  • LSTA 1980
  • Country
  • INKT United States
  • LSTA United States
  • Employees
  • INKT N/A
  • LSTA N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • INKT Health Care
  • LSTA Health Care
  • Exchange
  • INKT Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • INKT 28.8M
  • LSTA 22.5M
  • IPO Year
  • INKT 2021
  • LSTA N/A
  • Fundamental
  • Price
  • INKT $21.07
  • LSTA $2.41
  • Analyst Decision
  • INKT Hold
  • LSTA Strong Buy
  • Analyst Count
  • INKT 3
  • LSTA 2
  • Target Price
  • INKT $37.50
  • LSTA $23.50
  • AVG Volume (30 Days)
  • INKT 2.9M
  • LSTA 56.7K
  • Earning Date
  • INKT 08-12-2025
  • LSTA 08-11-2025
  • Dividend Yield
  • INKT N/A
  • LSTA N/A
  • EPS Growth
  • INKT N/A
  • LSTA N/A
  • EPS
  • INKT N/A
  • LSTA N/A
  • Revenue
  • INKT N/A
  • LSTA $1,000,000.00
  • Revenue This Year
  • INKT N/A
  • LSTA N/A
  • Revenue Next Year
  • INKT N/A
  • LSTA N/A
  • P/E Ratio
  • INKT N/A
  • LSTA N/A
  • Revenue Growth
  • INKT N/A
  • LSTA N/A
  • 52 Week Low
  • INKT $4.56
  • LSTA $1.87
  • 52 Week High
  • INKT $76.00
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • INKT 55.06
  • LSTA 45.37
  • Support Level
  • INKT $23.11
  • LSTA $2.49
  • Resistance Level
  • INKT $76.00
  • LSTA $3.09
  • Average True Range (ATR)
  • INKT 7.20
  • LSTA 0.26
  • MACD
  • INKT 1.20
  • LSTA -0.04
  • Stochastic Oscillator
  • INKT 23.55
  • LSTA 26.50

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: